Code | 06235 | ||||||||||
MA number | EU/1/11/672/006 | ||||||||||
Product Form: | sus ijp 1x150 mg (striek.napln.skl.+2 ihly) + 1x100 mg (striek.napln.skl.+2 ihly) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Janssen - Cilag International N.V., Belgium | ||||||||||
Therapeutic Class: | 68 - ANTIPSYCHOTICA (NEUROLEPTICA) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | glass pre-filled syringe | ||||||||||
Route of admin.: | Intramuscular use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 8(3) application - known active substance |
MA issued: | 04.03.2011 |
SmPC + PL: |
|
Dokument: |
|
Safety feature | Yes |
Data update: | 12.06.2019 |